Kevin West (R‑Moore) and Rick West (R‑Heavener), asks the Oklahoma Supreme Court to overturn Oklahoma Corporation Commission orders that signed off on about $1.5 billion in 2023 costs: roughly $530 ...

Positive Phase 3 topline results demonstrating envudeucitinib’s leading skin clearance, meaningful symptom improvement and a favorable safety ...

The Pittsburgh Symphony Orchestra has announced its 2026–2027 season, featuring the PNC Pops series, Movies with the PSO, and ...

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...

Alumis is preparing to file its oral TYK2 inhibitor envudeucitinib as a treatment for psoriasis later this year, after a pair of positive phase 3 trials. The South San Francisco biotech said ...

Three Republican state representatives are asking the Oklahoma Supreme Court to throw out fuel and power costs approved for ONG, OG&E and PSO.

As Oklahoma Severe Weather Awareness Week continues, Public Service Company of Oklahoma is urging customers to take steps now to stay safe and prepared as the t ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

The season will feature shows with Jeff Goldblum and the Mildred Snitzer Orchestra and Hamilton’s Leslie Odom Jr.

Officials report scattered damage, a road closure and more than 6,000 power outages after severe storms moved through Friday evening.

Eli Lilly’s phase 3 ADorable-1 trial of Ebglyss in paediatric patients with moderate-to-severe atopic dermatitis meets primary and key secondary endpoints: Indianapolis Tuesday, ...